Moderna (MRNA) Change in Taxes (2021 - 2024)

Moderna (MRNA) has reported Change in Taxes for 4 consecutive years, with -$2.0 million the latest figure, recorded in Q3 2024.

• On a quarterly basis, Change in Taxes fell 122.22% year-over-year to -$2.0 million in Q3 2024; TTM through Sep 2024 was -$51.0 million, a 410.0% decrease from a year earlier, with the FY2023 full-year figure at $15.0 million, up 101.81% from the prior year.
• Change in Taxes was -$2.0 million for Q3 2024 at Moderna, up from -$45.0 million in the prior quarter.
• Over five years, Change in Taxes peaked at $716.0 million in Q1 2022 and troughed at -$1.2 billion in Q2 2022.
• A 4-year average of $333333.3 and a median of $7.0 million in 2023 frame the typical range for Change in Taxes.
• The widest YoY moves for Change in Taxes: up 695.56% in 2022, down 533.1% in 2022.
• Over 4 years, Change in Taxes stood at $311.0 million in 2021, then tumbled by 105.79% to -$18.0 million in 2022, then jumped by 138.89% to $7.0 million in 2023, then slumped by 128.57% to -$2.0 million in 2024.
• The last three Change in Taxes figures came in at -$2.0 million (Q3 2024), -$45.0 million (Q2 2024), and -$11.0 million (Q1 2024), per Business Quant data.